arXiv ScienceSearch

arXiv subjects

Bernhard Strasser

Publications and source records attributed to Bernhard Strasser.

9 recordsLinked to original sources

The 2024 MRSI Data Processing and Quantification Challenge Synthetic Dataset

Synthetic data is central to magnetic resonance spectroscopy method development because they provide ground truths for software validation, reproducible benchmarking, and machine- and deep-learning training. In MRSI, synthetic data must capture spatially varying anatomy, field inhomogeneity, nuisance signals, and measurement effects. The 2024 MRSI Data Processing and Quantification Challenge Synthetic Dataset is a simulated 3T brain FID-MRSI resource with ground-truth metabolite maps developed as a controlled testbed for MRSI processing and quantification methods. Subject-specific simulations used anatomical images and field maps from Human Connectome Project subjects. Tissue masks, quantum-mechanically simulated metabolite basis functions, in vivo-derived macromolecular components, Bloch-simulated post-WET residual water, registered in vivo lipid signals, spectral baseline, $B_0$-dependent frequency shifts, Voigt lineshape variations, and complex Gaussian noise were combined in a forward model. Water and lipid signals were synthesized on a high-resolution grid and Fourier-truncated to the final echo-planar spectroscopic imaging grid to model the finite spatial point spread function. This resource has 24 training and 8 testing datasets containing contaminated FID-MRSI data, anatomical images, $B_0$ maps, metadata, and ground-truth metabolite and component signals. Forward-model parameters are documented, including tissue-specific metabolite concentrations and relaxation times, macromolecular amplitude ratios, the water model, noise, and field-inhomogeneity ranges. This synthetic benchmark supports development and comparison of MRSI processing, nuisance-signal removal, and metabolite-quantification methods, while enabling method evaluation. It illustrates how characterized synthetic data can support rigorous evaluation when ground truth is difficult or impossible to obtain.

physics.med-ph

Synthetic Data in MR Spectroscopy: Current Practices, Applications, and Considerations

The use of synthetic data has emerged as an essential tool in Magnetic Resonance Spectroscopy (MRS) research and applications, providing advantages for optimization of acquisition, software validation, deep learning applications, and enhanced reproducibility. Importantly, synthetic data addresses challenges of limited training data availability, particularly for clinical populations, and offers controlled solutions for investigating uncertainties and unexplained variance with in vivo data. This work provides a review and evaluation of current practices in the use and generation of synthetic data within the MRS field. Conducted by the MRS Synthetic Data Working Group under the Code & Data Sharing Committee of the MRS Study Group of the International Society for Magnetic Resonance in Medicine (ISMRM), this manuscript encompasses existing literature, supplemented by collective experience and in-house methodologies.

physics.med-ph

Optimization and application of ultra-high field preclinical high-resolution and 3D 1H-MRSI using compressed sensing

Proton magnetic resonance spectroscopic imaging (1H-MRSI) at ultra-high field has seen an increase in usage in the preclinical field. Challenges related to long acquisition time and low concentration of brain metabolites in the rodent brain have led to the development and application of acceleration schemes for 3D-1H-MRSI, such the undersampling technique Compressed Sensing (CS). This present study aims to explore the CS tool in the context of preclinical in vivo application in order to achieve high-resolution MRSI acquisition in both 2D with an in-plane increase and 3D/multi-slice acquisition with through-plane. The parameters are explored to achieve the highest acceleration possible as a way to make 3D as time efficient as possible. Results of the parameter study showed that an acceleration factor (AF) of 4 was possible with the right sampling size of the core at the center of the k-space. With this specific set, higher matrix size resulting in sub 1 {\mu}L nominal voxel size was explored with 2D-FID-MRSI and 9 supplementary phase-encoding/slices were added to achieve 3D-FID-MRSI. The spectral quality and the metabolic maps were accurate enough in the comparison with the non-accelerated 2D-FID-MRSI, within the slice of interest. Issues related with the point spread function (PSF) were noted throughout the different usage of CS. Our work presents a robust and effective protocol to achieve 3D-1H-MRSI using CS in order to reach an acquisition time below the 30 minutes bar, with minimal technical limitations and high-quality acquisition.

physics.med-ph

Deep-ER: Deep Learning ECCENTRIC Reconstruction for fast high-resolution neurometabolic imaging

Introduction: Altered neurometabolism is an important pathological mechanism in many neurological diseases and brain cancer, which can be mapped non-invasively by Magnetic Resonance Spectroscopic Imaging (MRSI). Advanced MRSI using non-cartesian compressed-sense acquisition enables fast high-resolution metabolic imaging but has lengthy reconstruction times that limits throughput and needs expert user interaction. Here, we present a robust and efficient Deep Learning reconstruction to obtain high-quality metabolic maps. Methods: Fast high-resolution whole-brain metabolic imaging was performed at 3.4 mm$^3$ isotropic resolution with acquisition times between 4:11-9:21 min:s using ECCENTRIC pulse sequence on a 7T MRI scanner. Data were acquired in a high-resolution phantom and 27 human participants, including 22 healthy volunteers and 5 glioma patients. A deep neural network using recurring interlaced convolutional layers with joint dual-space feature representation was developed for deep learning ECCENTRIC reconstruction (Deep-ER). 21 subjects were used for training and 6 subjects for testing. Deep-ER performance was compared to conventional iterative Total Generalized Variation reconstruction using image and spectral quality metrics. Results: Deep-ER demonstrated 600-fold faster reconstruction than conventional methods, providing improved spatial-spectral quality and metabolite quantification with 12%-45% (P<0.05) higher signal-to-noise and 8%-50% (P<0.05) smaller Cramer-Rao lower bounds. Metabolic images clearly visualize glioma tumor heterogeneity and boundary. Conclusion: Deep-ER provides efficient and robust reconstruction for sparse-sampled MRSI. The accelerated acquisition-reconstruction MRSI is compatible with high-throughput imaging workflow. It is expected that such improved performance will facilitate basic and clinical MRSI applications.

eess.IV

Noise-reduction techniques for 1H-FID-MRSI at 14.1T: Monte-Carlo validation & in vivo application

Proton magnetic resonance spectroscopic imaging (1H-MRSI) is a powerful tool that enables the multidimensional non-invasive mapping of the neurochemical profile at high-resolution over the entire brain. The constant demand for higher spatial resolution in 1H-MRSI led to increased interest in post-processing-based denoising methods aimed at reducing noise variance. The aim of the present study was to implement two noise-reduction techniques, the Marchenko-Pastur principal component analysis (MP-PCA) based denoising and the low-rank total generalized variation (LR-TGV) reconstruction, and to test their potential and impact on preclinical 14.1T fast in vivo 1H-FID-MRSI datasets. Since there is no known ground truth for in vivo metabolite maps, additional evaluations of the performance of both noise-reduction strategies were conducted using Monte-Carlo simulations. Results showed that both denoising techniques increased the apparent signal-to-noise ratio SNR while preserving noise properties in each spectrum for both in vivo and Monte-Carlo datasets. Relative metabolite concentrations were not significantly altered by either methods and brain regional differences were preserved in both synthetic and in vivo datasets. Increased precision of metabolite estimates was observed for the two methods, with inconsistencies noted on lower concentrated metabolites. Our study provided a framework on how to evaluate the performance of MP-PCA and LR-TGV methods for preclinical 1H-FID MRSI data at 14.1T. While gains in apparent SNR and precision were observed, concentration estimations ought to be treated with care especially for low-concentrated metabolites.

physics.med-ph

Fast high-resolution metabolite mapping in the rat brain using 1H-FID-MRSI at 14.1T

Magnetic resonance spectroscopic imaging (MRSI) enables the simultaneous non-invasive acquisition of MR spectra from multiple spatial locations inside the brain. While 1H-MRSI is increasingly used in the human brain, it is not yet widely applied in the preclinical settings, mostly because of difficulties specifically related to very small nominal voxel size in the rodent brain and low concentration of brain metabolites, resulting in low signal-to-noise ratio SNR. In this context, we implemented a free induction decay 1H-MRSI sequence (1H-FID-MRSI) in the rat brain at 14.1T. We combined the advantages of 1H-FID-MRSI with the ultra-high magnetic field to achieve higher SNR, coverage and spatial resolution in the rodent brain, and developed a custom dedicated processing pipeline with a graphical user interface: MRS4Brain toolbox. LCModel fit, using the simulated metabolite basis-set and in-vivo measured MM, provided reliable fits for the data at acquisition delays of 1.3 and 0.94 ms. The resulting Cram\'er-Rao lower bounds were sufficiently low (<30%) for eight metabolites of interest, leading to highly reproducible metabolic maps. Similar spectral quality and metabolic maps were obtained between 1 and 2 averages, with slightly better contrast and brain coverage due to increased SNR in the latter case. Furthermore, the obtained metabolic maps were accurate enough to confirm the previously known brain regional distribution of some metabolites. The acquisitions proved high reproducibility over time. We demonstrated that the increased SNR and spectral resolution at 14.1T can be translated into high spatial resolution in 1H-FID-MRSI of the rat brain in 13 minutes, using the sequence and processing pipeline described herein. High-resolution 1H-FID-MRSI at 14.1T provided reproducible and high-quality metabolic mapping of brain metabolites with significantly reduced technical limitations.

physics.med-ph

ECCENTRIC: a fast and unrestrained approach for high-resolution in vivo metabolic imaging at ultra-high field MR

A novel method for fast and high-resolution metabolic imaging, called ECcentric Circle ENcoding TRajectorIes for Compressed sensing (ECCENTRIC), has been developed and implemented at 7 Tesla MRI. ECCENTRIC is a non-Cartesian spatial-spectral encoding method optimized to accelerate magnetic resonance spectroscopic imaging (MRSI) with high signal-to-noise at ultra-high field. The approach provides flexible and random ($k,t$) sampling without temporal interleaving to improve spatial response function and spectral quality. ECCENTRIC needs low gradient amplitudes and slew-rates that reduces electrical, mechanical and thermal stress of the scanner hardware, and is robust to timing imperfection and eddy-current delays. Combined with a model-based low-rank reconstruction, this approach enables simultaneous imaging of up to 14 metabolites over the whole-brain at 2-3mm isotropic resolution in 4-10 minutes. In healthy volunteers ECCENTRIC demonstrated unprecedented spatial mapping of fine structural details of human brain neurochemistry. This innovative tool introduces a novel approach to neuroscience, providing new insights into the exploration of brain activity and physiology.

physics.med-ph

Predicting dynamic, motion-related changes in B0 field in the brain at a 7 T MRI using a subject-specific fine-tuned U-net

Subject movement during the magnetic resonance examination is inevitable and causes not only image artefacts but also deteriorates the homogeneity of the main magnetic field (B0), which is a prerequisite for high quality data. Thus, characterization of changes to B0, e.g. induced by patient movement, is important for MR applications that are prone to B0 inhomogeneities. We propose a deep learning based method to predict such changes within the brain from the change of the head position to facilitate retrospective or even real-time correction. A 3D U-net was trained on in vivo brain 7T MRI data. The input consisted of B0 maps and anatomical images at an initial position, and anatomical images at a different head position (obtained by applying a rigid-body transformation on the initial anatomical image). The output consisted of B0 maps at the new head positions. We further fine-tuned the network weights to each subject by measuring a limited number of head positions of the given subject, and trained the U-net with these data. Our approach was compared to established dynamic B0 field mapping via interleaved navigators, which suffer from limited spatial resolution and the need for undesirable sequence modifications. Qualitative and quantitative comparison showed similar performance between an interleaved navigator-equivalent method and proposed method. We therefore conclude that it is feasible to predict B0 maps from rigid subject movement and, when combined with external tracking hardware, this information could be used to improve the quality of magnetic resonance acquisitions without the use of navigators.

cs.CV

A comparison of 7 Tesla MR spectroscopic imaging and 3 Tesla MR fingerprinting for tumor localization in glioma patients

This paper investigates the correlation between magnetic resonance spectroscopic imaging (MRSI) and magnetic resonance fingerprinting (MRF) in glioma patients by comparing neuro-oncological markers obtained from MRSI to T1/T2 maps from MRF. Data from 12 consenting patients with gliomas were analyzed by defining hotspots for T1, T2 and various metabolic ratios, and comparing them using S{\o}rensen-Dice Similarity Coefficients (DSCs) and the distances between their centers of intensity (COIDs). Median DSCs between MRF and the tumor segmentation were 0.73 (T1) and 0.79 (T2). The DSCs between MRSI and MRF were highest for Gln/tNAA (T1: 0.75, T2: 0.80, tumor: 0.78), followed by Gly/tNAA (T1: 0.57, T2: 0.62, tumor: 0.54) and tCho/tNAA (T1: 0.61, T2: 0.58, tumor: 0.45). The median values in the tumor hotspot were T1=1724 ms, T2=86 ms, Gln/tNAA=0.61, Gly/tNAA=0.28, Ins/tNAA=1.15, and tCho/tNAA=0.48, and, in the peritumoral region, were T1=1756 ms, T2=102ms, Gln/tNAA=0.38, Gly/tNAA=0.20, Ins/tNAA=1.06, and tCho/tNAA=0.38, and, in the NAWM, were T1=950 ms, T2=43 ms, Gln/tNAA=0.16, Gly/tNAA=0.07, Ins/tNAA=0.54, and tCho/tNAA=0.20. The results of this study constitute the first comparison of 7T MRSI and 3T MRF, showing a good correspondence between these methods.

physics.med-ph